Promega launches benchtop CE DNA analyzer
Promega has debuted Spectrum Compact CE, a benchtop capillary electrophoresis (CE) instrument. Read More
Arrakis touts paper on RNA-targeted small molecules
Arrakis Therapeutics is touting the publication of a new paper that demonstrates the capabilities of its proprietary photoaffinity labeling/next-generation sequencing technology for the systemic identification of binding sites in RNA molecules as a method to facilitate the discovery of RNA-targeted small molecule medicines. The research was published in the American Chemical Society's ACS Chemical Biology. Read More
Irisys to manufacture Qualigen COVID-19 drug
Qualigen Therapeutics has signed a contract with Irisys for the production of AS1411, Qualigen's lead candidate for the treatment of viral diseases including COVID-19. Read More
Provention Bio, Amgen begin mAb trial for celiac disease
Provention Bio has begun a phase IIB study of PRV-015, an anti-interleukin-15 monoclonal antibody (mAb), in adult patients with nonresponsive celiac disease. The drug is being developed in collaboration with Amgen as potentially the first approved therapeutic for celiac disease. Read More
Thomas Jefferson University selected to advance CoraVax
The Commonwealth of Pennsylvania has awarded Thomas Jefferson University a grant for the development of CoraVax, a novel COVID-19 vaccine. Read More
Moderna to potentially supply Japan with 40M doses of COVID-19 vaccine
Moderna is in discussion with the Ministry of Health, Labour, and Welfare of Japan to potentially purchase 40 million or more doses of its messenger RNA vaccine candidate against COVID-19 to support Japan's efforts to secure vaccines as soon as possible. Read More
Thermo Fisher opens manufacturing site for COVID-19 viral transport media
Thermo Fisher Scientific has opened its new $40 million facility in Lenexa, KS, dedicated to viral transport media production. The groundbreaking ceremony was held on August 28. Read More
Verndari secures BARDA funding for skin patch vaccine
Biopharmaceutical firm Verndari has secured funding from the Biomedical Advanced Research and Development Authority (BARDA), a U.S. federal health agency, to support development of its VaxiPatch microneedle dermal patch vaccine technology. Read More
NCI, Cancer Research U.K. fund project to spur cancer research
The U.S. National Cancer Institute (NCI) has partnered with Cancer Research U.K. to fund Cancer Grand Challenges, an international initiative to support new ideas for cancer research. Read More
VBI Vaccines move two COVID-19 vaccines to clinical trials
VBI Vaccines said that it has selected two of its COVID-19 vaccine candidates to proceed to a phase I/II clinical study expected to begin around the end of the year. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
